Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. 1995

S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
Department of Medicine, SUNY Health Science Center, Syracuse 13210.

X-linked recessive nephrolithiasis (XRN) was described in a large kindred in which nephrolithiasis; proximal tubular dysfunction, proteinuria, nephrocalcinosis, and renal failure occur only in males. Carrier females are asymptomatic, but formal studies of them have not been done. The gene for XRN has been mapped to the pericentromeric region of the X chromosome, close to the loci for several eye disease genes. We studied six affected males, 13 carrier females, and 25 normal members of this family including 7 females whose genetic haplotype predicted them to be carriers. Studies were done in the Clinical Research Unit on a diet containing 400 mg of calcium and 2 g of sodium, and by an additional outpatient urine collection was obtained on a 1-g calcium intake. Hypercalciuria occurred in five of six affected males, 4 of 12 carrier females, and three of seven predicted carriers. Significant proteinuria was present in all affected males and in no other subjects. Low-molecular-weight proteinuria was present in all affected males: the excretion of alpha 1-microglobulin exceeded normal by 3- to 14-fold, of beta 2-microglobulin exceeded normal by 100- to 400-fold, and of retinol-binding protein exceeded normal by 1,000- to 3,000-fold. The excretion of these proteins was less strikingly elevated in carrier females, but the excretion of alpha 1-microglobulin was abnormal in 9 of 15 carriers, beta 2-microglobulin was abnormal in 12 of 15, and retinolbinding protein in was abnormal 12 of 13, and this pattern was similar in predicted carriers. The urinary concentrating ability was abnormal in four affected males with renal insufficiency but normal in all other subjects. Urinary wasting of potassium, phosphorous, and glucose occurred infrequently, and no subject was hypouricemic. Formal ophthalmologic studies were normal in five affected males. Thus, the most consistent urinary abnormalities in XRN are hypercalciuria and low-molecular-weight proteinuria, the latter of which appears to be a marker for the carrier state.

UI MeSH Term Description Entries
D007669 Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE. Kidney Stones,Renal Calculi,Nephrolith,Renal Calculus,Calculi, Kidney,Calculi, Renal,Calculus, Kidney,Calculus, Renal,Kidney Calculus,Kidney Stone,Stone, Kidney,Stones, Kidney
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
October 1981, Clinical genetics,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
November 1988, Clinical genetics,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
April 1992, The New England journal of medicine,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
September 1991, The New England journal of medicine,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
January 1989, Enzyme,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
December 2002, Clinical genetics,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
September 2001, European journal of human genetics : EJHG,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
May 1998, The Journal of pediatrics,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
January 2015, Clinical & experimental ophthalmology,
S C Reinhart, and A G Norden, and M Lapsley, and R V Thakker, and J Pang, and A M Moses, and P A Frymoyer, and M J Favus, and J A Hoepner, and S J Scheinman
July 1994, American journal of medical genetics,
Copied contents to your clipboard!